Cargando…
Intermolecular Interactions in Crystal Structures of Imatinib-Containing Compounds
Imatinib, one of the most used therapeutic agents to treat leukemia, is an inhibitor that specifically blocks the activity of tyrosine kinases. The molecule of imatinib is flexible and contains several functional groups able to take part in H-bonding and hydrophobic interactions. Analysis of molecul...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7731260/ https://www.ncbi.nlm.nih.gov/pubmed/33255944 http://dx.doi.org/10.3390/ijms21238970 |